May 25, 2011
Innovation at the intersection of creativity and automation.
In the same way that the guillotine concentrates the senses, the need to improve productivity in the pharmaceutical industry has become a life-or-death imperative.
April 28, 2011
Why don’t computer systems help me as much as I think they should?
Complete and clear requirements are a critical element in the successful design and execution of workflows for pharmacometric analyses.
April 14, 2011
Scientific workflows—the knowledge-generating engines of R&D.
The interdisciplinary collaboration needed to specify workflow requirements, to achieve consensus on study methods, and to detail how to interpret and present results is surely the most critical step for improving productivity in the Pharma of the Future℠.
March 30, 2011
Productivity is not a four-letter word.
On that global stage called “The Pharmaceutical Industry,” one of the dramas unfolding is the urgency to improve productivity at all levels—industry, team, and individual.
November 2, 2010
You WILL innovate!
Innovation is something that comes from a mysterious creative force that strikes like lightning to the fortunate inventor—or is it?
September 15, 2010
But. . .my projects are special.
To be successful, interdisciplinary R&D needs a conceptual synthesis to bridge the disciplines and allow research results from one discipline to be applied to the questions of another. Disease-drug models can provide this conceptual synthesis.
August 19, 2010
Not too complicated for words.
Increasing the transparency, speed, and reliability of information flow among researchers in integrated project teams is a critical step in improving research productivity.
July 1, 2010
A Drug Is Not a Jet Plane, or Is It?
The innovations of model-based drug development must be implemented with full attention paid to its effects on the upstream and downstream components of the larger enterprise.
April 28, 2010
Disambiguation
Disambiguation means to remove ambiguity. It seems to me that the smarter the people and the more complex the topic, the more disambiguation is necessary.
March 23, 2010
Origins of Pharma of the Future℠
The pharma industry has a critical need to establish model-based drug development. The Pharma of the Future℠ (PoF) program is a research initiative to support this important enterprise transformation. In this blog entry, we tell the story of the program that inspired PoF.
Previous
